{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:59:00Z","timestamp":1793627940246,"version":"4.5.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,27]]},"DOI":"10.1097\/id.0000000000000232","type":"journal-article","created":{"date-parts":[[2015,2,28]],"date-time":"2015-02-28T05:10:00Z","timestamp":1425100200000},"source":"Crossref","is-referenced-by-count":6,"title":["Teriparatide Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw Associated With Dental Implants"],"prefix":"10.1097","volume":"Publish Ahead of Print","author":[{"given":"Re-Mee","family":"Doh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonse","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210228","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic.","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"R2-17-20210228","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hed.21380","article-title":". Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.","volume":"33","author":"Lee","year":"2011","journal-title":"Head Neck"},{"key":"R3-17-20210228","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.oraloncology.2013.05.012","article-title":". Conservative management of bisphosphonate-related osteonecrosis of the jaws: Staging and treatment outcomes.","volume":"49","author":"Lerman","year":"2013","journal-title":"Oral Oncol"},{"key":"R4-17-20210228","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4047\/jap.2014.6.1.39","article-title":". Three-dimensional accuracy of different correction methods for cast implant bars.","volume":"6","author":"Kwon","year":"2014","journal-title":"J Adv Prosthodont"},{"key":"R5-17-20210228","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.bjoms.2013.06.011","article-title":". Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: A case series.","volume":"51","author":"Lopez-Cedrun","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R6-17-20210228","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00198-009-0973-3","article-title":". Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: Five cases.","volume":"21","author":"Park","year":"2010","journal-title":"Osteoporos Int"},{"key":"R7-17-20210228","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/ID.0b013e3182703c4f","article-title":". Mandibular bisphosphonate-related osteonecrosis after dental implant rehabilitation: A case report.","volume":"21","author":"Sverzut","year":"2012","journal-title":"Implant Dent"},{"key":"R9-17-20210228","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/er.2004-0006","article-title":". Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use.","volume":"26","author":"Hodsman","year":"2005","journal-title":"Endocr Rev"},{"key":"R10-17-20210228","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw.","volume":"363","author":"Cheung","year":"2010","journal-title":"N Engl J Med"},{"key":"R11-17-20210228","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.joms.2006.10.076","article-title":"Resolution of bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone rhPTH(1-34).","volume":"65","author":"Harper","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"R12-17-20210228","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","article-title":". Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws.","volume":"23","author":"Kwon","year":"2012","journal-title":"Osteoporos Int"},{"key":"R13-17-20210228","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.081176","article-title":"Resolution of osteonecrosis of the jaw after teriparatide recombinant human PTH-(1-34) therapy.","volume":"36","author":"Lau","year":"2009","journal-title":"J Rheumatol"},{"key":"R14-17-20210228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1754-4505.2009.00128.x","article-title":". Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: A review of the literature and a case report.","volume":"30","author":"Narongroeknawin","year":"2010","journal-title":"Spec Care Dentist"},{"key":"R15-17-20210228","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.oooo.2012.09.006","article-title":". Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.","volume":"115","author":"Ohbayashi","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R16-17-20210228","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","article-title":". Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw.","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporos Int"},{"key":"R17-17-20210228","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00198-009-1168-7","article-title":". Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis.","volume":"21","author":"Stepan","year":"2010","journal-title":"Osteoporos Int"},{"key":"R20-17-20210228","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":". Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"R21-17-20210228","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00198-012-1918-9","article-title":". Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.","volume":"24","author":"Narvaez","year":"2013","journal-title":"Osteoporos Int"}],"container-title":["Implant Dentistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008505-201504000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:52:09Z","timestamp":1646218329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008505-900000000-99628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1097\/id.0000000000000232","relation":{},"ISSN":["1056-6163"],"issn-type":[{"value":"1056-6163","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,27]]}}}